|Bid||0.00 x 0|
|Ask||9.75 x 400|
|Day's Range||6.30 - 6.67|
|52 Week Range||5.60 - 12.80|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.00|
PLx Pharma Inc (NASDAQ:PLXP) is a small-cap stock with a market capitalization of USD $59.68M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies,Read More...
NEW YORK, NY / ACCESSWIRE / November 10, 2017 / PLx Pharma, Inc. (NASDAQ: PLXP ) will be discussing their earnings results in their Q3 Earnings Call to be held on Friday, November 10, 2017 at 8:30 AM Eastern ...
The Houston-based company said it had a loss of 44 cents per share. The biotechnology company posted revenue of $62,300 in the period. Its adjusted revenue was $62,000. PLx Pharma shares have decreased ...
HOUSTON, Nov. 09, 2017-- PLx Pharma Inc., a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81 mg, announced today its ...
On a per-share basis, the New York-based company said it had a loss of 36 cents. Losses, adjusted for non-recurring gains, came to 54 cents per share. The biotechnology company posted revenue of $376,000 ...